pan-JAK inhibitor
LEO Pharma Scores FDA Approval for Anzupgo as First Treatment for Chronic Hand Eczema
LEO Pharma; Anzupgo; delgocitinib; FDA approval; chronic hand eczema; pan-JAK inhibitor; moderate-to-severe CHE; topical treatment
Actionable Insights Powered by AI
LEO Pharma; Anzupgo; delgocitinib; FDA approval; chronic hand eczema; pan-JAK inhibitor; moderate-to-severe CHE; topical treatment